FDA Investigator Penny H Mccarver

Penny H Mccarver has inspections in 7 countries as of 07 Sep 2023. Penny H Mccarver has collaborated with a combinined 5101 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
144
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Germany, United States of America, Switzerland, Italy, Norway, Canada
Co-Investigator(s):
Aaron P Wozniak, Adam R Cooke, Alan P Kurtzberg, Amy Devlin, PhD, Amy H Ruble, Anissa M Cheung, Ann B Borromeo, Anthony F Lorenzo, Anthony S Puckett, Ashutosh Rao, PhD, Babatunde D Babalola, Barbara M Frazier, Beth F Fritch, Betsy C Galliher, Billy M Battles, Bo Chi, PhD, Bonita S Chester, Brandy D Brown, Brenda Rivera, Brett D Weed, Brett Weed, Brittny C Cargo, Burnell M Henry, Carlos A Ortiz, Carlos M Gonzalez, Carol F Robinson, Carolyn A Renshaw, Cassandra L Abellard, Catherine J Laufmann, CDR Cecily Jones, CDR Jeremy L Wally, PhD, CDR Thomas R Berry, PPh, Charisse K Green, Charles M Edwards, Chateryl K Washington, Cherrie A Zachary, Cherry R Valerio, Cheryl Llove Harris, Christian D Lynch (CDL), Christie B Rice, Christopher B May, Christopher Downey, PhD, Christopher J Adams, Christopher S Keating, Christopher T Middendorf, Claire M Minden, Claudette D Brooks, Constance Y Fears, Cynthia Jim, CSO, D Ross Spears, PhD, Daphne Santiago, PhD, David T Glover, David Williams, Deborah A Greco, Demario L Walls, Denise M Digiulio, Derek C Price, Devaugh Edwards, Devaughn Edwards, Deyaa Shaheen, Diane E Bruce, Donald C Obenhuber, PhD, Dr. Gang Wang, PhD, Dr. Jason R Caballero, Edward Deberry, Edward Lukeman, Eileen J Bannerman, Eliezar Ramos, Enada F Archibold, Eric S Clevenger, Eric S Weilage, Erin C Hill, Ernest H Blackwood, Esra Toussaint, Fabian Nchaparro Rodriguez, Frank Wackes, Gabriel R Mclemore, Gamal A Norton, Gene D Arcy, Geraldine D Sanders, Gerraldine Sanders, Gideon N Esuzor, Hai L Phung, Hai Lent Phung, Hai Lien Phung, Hai Lien T Phung, Haruhiko Murata, Hector A Carrero, Hei Lient Phung, Ibad U Khan, Ivy E Sweeney, Jacek Cieslak, PhD, Jacqueline D Mitchell, Jacqueline Mdiaz Albertini, James P Lewis, Jr, Jamirya S Weatherly, Jaqueline Mitchell, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jason R Nickelsen, Jawaid Hamid, Jawid Hamid, Jean Lhu Primmer, Jee Chung, PhD, Jennifer D Hollstrom, Jennifer L Bridgewater, Jessica L Pressley, Joanne T Gabay, Joe A Odom, Johnetta F Walters, Jonathan G Swoboda, Jose Alopez Rubet, Jose E Melendez, DDC, Joseph F Owens, Joseph J Vannelli, Joseph R Lambert, Julie D Bringger, Kara D Dobbin, Karen Takahashi, Kathleen D Culver, Katrina B Mosley Sloan, Kenneth H Williams, Khalid M Khan, Kip J Hanks, Kristen D Evans, Lakeesha M Foster, Lance M De Souza, MBA, Lareese K Thomas, Larry K Hampton, Lauryl A Smith, Lawrence Carter, III, Lawrence Thomas, Leah Andrews, Leah M Andrews, Leo J Lagrotte, Leonard H Lavi, Leopold Kong, PhD, Lesley K Satterwhite, Leslie Arivera Rosado, PhD, Leslie W Gilbert, Leslie W Jones, Libia M Lugo, Lillie D Witcher, Linda F Murphy, Linda M Athey, LT Daveta L Bailey, LT Tamara J Henderson, Luis A Carrion, Luis M Burgos Medero, Marc A Alston, Marcellinus D Dordunoo, Marcia Gelber, Maridalia Torres Irizarry, Marie F Morin, Marisa E Stock, Marla A Cassidy, Marvin D Jones, Mary Kaulee, Matthew G Brown, Melanie M Walker, Melissa I Michurski, Melissa J Garcia, Metitia G Sanders, Metitia M Gramby, Michael E Maselli, Michael J Kuchta, Michael J Vardon, Michele L Forster, PhD, Michele L Obert, Michelle Y Clark Stuart, Mihaly S Ligmond, Mindy M Chou, Monica Cburgos Garcia, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Myoshi M Francis, Nakesha J Jackson, Nicole A Lloyd, Nicole E Knowlton, Noreen Muniz, Nydia E Colon, Omotunde O Osunsanmi, Pankaj H Amin, Panney H Mccarver, Patricia F Hudson, Patricia F Hughes, PhD, Paul A Bonneau, Paul D Keller, Paul Mouris, Paul W Keller, Paula A Trost, Paula R Katz, Perry H Gambrell, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Priscilla M Pastrana, R Edwadebey Deberry, Rachael A Moliver, Rachael L Cook, Rafael Nevarez, Rafael Nevarez Nieves, Randa Melhem, PhD, Randy L Clarida, Reba A Gates, Rebecca Rodriguez, Rhonda Alexander, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert L Lewis, Jr, Robert Q Green, Rose M Ashley, Safronia Jenkins, Saied A Asbagh, Samantha J Bradley, Sandra A Hughes, Santos E Camara, Sarah E Mcmullen, Sarah L Holliday, Sayeeda Hdabe, Scott T Ballard, Seneca D Toms, Sharna D Pratt, Sharon K Thoma, PharmD, Shirley S Brown, Simon Williams, PhD, Simone E Pitts, Sonya M Edmonds, State Agency, Stephen D Brown, Steven A Rubin, Steven D Kehoe, Steven Fong, MS, PhD, Steven J Rush, Steven M Weinman, Susan D Yuscius, Susan M Jackson, Susan O Oladeji, Suzanne N Vallez, Tajah L Blackburn, Tamara M Casselman, Tamara M Felton, Tamika D Cathey, Tamil Arasu, PhD, Tammara A Newberry, Tammara A Stephens, Thao T Kwan, Thomas J Arista, Thomas R Barry, Thomas R Withers, Thuy T Nguyen, LCDR, Tomika L Bivens, Tonshina R Hall, Tracy K Bell, Tracy L Ramseur, Tracy R Ball, Trang N Cox, Tsedenia Woldehanna, Vanessa E Coulter, Veronica Fuentes, MS, Vicky C Stoakes, Vicky L Cruz, Vincent M Williams, Viviana Matta, Vlada Matusovsky, Walden H Lee, Whitney F Hook, William P Tonkins, Xianghong Jing (Emily), PhD, Xiao Wang, Xiaoxiao Pan, PhD, Xiomara Copeland, Xuhong Li, Yiyue Zhang (nmi), PhD, Yuan Chia Kuo, Yun Wu, PhD, Yvonne C Mcknight, Zhenzhen Liu, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Penny H Mccarver's Documents

Publish Date Document Type Title
February, 2003 EIR S.s.s. Company (international) - EIR, 2003-02-06
July, 2002 FDA 483 Beaumont Products Inc. - Form 483, 2002-07-26
March, 2002 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2002-03-22
February, 2014 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2014-02-14
April, 2011 FDA 483 PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma - Form 483, 2011-04-06
May, 2003 FDA 483 Kiel Laboratories Inc - Form 483, 2003-05-27
September, 2014 FDA 483 Response Medi-Home Infusion Pharmacy - Form 483R, 2014-09-17
March, 2005 EIR Hospira, Inc. - EIR, 2005-03-24
November, 2001 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2001-11-09
February, 2014 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2014-02-14
January, 2000 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-01-14
August, 2006 EIR Patheon Manufacturing Services LLC - EIR, 2006-08-25
January, 2004 FDA 483 Response Kiel Laboratories Inc - Form 483R, 2004-02-05
September, 2007 EIR Novo Nordisk Pharmaceutical Industries, LP - EIR, 2007-09-28
October, 2004 EIR Solvay Pharmaceuticals Inc - EIR, 2004-10-08
March, 2013 FDA 483 Hospira, Inc. - Form 483, 2013-03-01
October, 2014 FDA 483 Summerton Drug Compounding and Dispensary - Form 483, 2014-10-17
August, 2006 FDA 483 Kiel Laboratories Inc - Form 483, 2006-08-14
September, 2006 EIR Novo Nordisk Pharmaceutical Industries, LP - EIR, 2006-09-22
March, 2004 FDA 483 Beaumont Products Inc. - Form 483, 2004-03-11
October, 2000 EIR Solvay Pharmaceuticals Inc - EIR, 2000-10-25
June, 2009 EIR LTS Lohmann Therapie-Systeme AG - EIR, 2009-06-18
November, 2000 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-11-21
September, 2003 EIR Societal CDMO Gainesville, LLC - EIR, 2003-09-09
September, 2012 FDA 483 PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma - Form 483, 2012-09-13
August, 2001 FDA 483 Mikart, LLC - Form 483, 2001-08-23
November, 2014 EIR Pharmascience Inc - EIR, 2014-11-17
May, 2002 FDA 483 Response Patheon API Manufacturing, Inc. - Form 483R, 2003-07-03
June, 2013 EIR Hospira, Inc. - EIR, 2013-06-13
July, 2001 FDA 483 Response Kiel Laboratories Inc - Form 483R, 2001-08-17
June, 2011 FDA 483 Hospira, Inc. - Form 483, 2011-06-17
May, 2008 EIR Societal CDMO Gainesville, LLC - EIR, 2008-05-02
June, 2014 EIR Hospira, Inc. - EIR, 2014-06-13
October, 2002 EIR GlaxoSmithKline LLC - EIR, 2002-10-17
September, 2001 EIR Piedmont LLC dba Voyant Beauty - EIR, 2001-09-11
May, 2006 FDA 483 CSL Plasma, Inc - Form 483, 2006-05-12
July, 2000 EIR Societal CDMO Gainesville, LLC - EIR, 2000-07-26
May, 2004 EIR Baxter Healthcare Corporation - EIR, 2004-05-06
April, 2014 FDA 483 Patheon Manufacturing Services LLC - Form 483, 2014-04-11
August, 2004 FDA 483 CSL Plasma, Inc - Form 483, 2004-08-06
September, 2008 FDA 483 FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2008-09-11
March, 2003 EIR Searle Chemicals Inc. - EIR, 2003-03-05
October, 2004 FDA 483 Pisgah Laboratories Inc - Form 483, 2004-10-27
December, 2000 EIR Patheon Manufacturing Services LLC - EIR, 2000-12-15
November, 2000 EIR Boc Group Inc - EIR, 2000-11-28
September, 2004 FDA 483 Response Kiel Laboratories Inc - Form 483R, 2004-09-09
July, 2004 EIR Merck Sharp & Dohme LLC - EIR, 2004-07-15
December, 2004 FDA 483 Diversified Healthcare Service - Form 483, 2004-12-16
May, 2002 FDA 483 Irix Manufacturing, Inc. - Form 483, 2002-05-23
April, 2000 FDA 483 NEXAIR, LLC - Form 483, 2000-04-21
March, 2002 FDA 483 Societal CDMO Gainesville, LLC - Form 483, 2002-03-07
November, 2006 FDA 483 Central Admixture Pharmacy Services Inc - Form 483, 2006-11-16
September, 2006 FDA 483 Response Novo Nordisk Pharmaceutical Industries, LP - Form 483R, 2006-10-09
July, 2000 FDA 483 Response Societal CDMO Gainesville, LLC - Form 483R, 2000-08-04
September, 2004 FDA 483 Kiel Laboratories Inc - Form 483, 2004-09-09
April, 2003 FDA 483 Liebel-Flarsheim Company LLC - Form 483, 2003-04-18
June, 2004 EIR Merck And Company Inc - EIR, 2004-06-17
January, 2004 FDA 483 Kiel Laboratories Inc - Form 483, 2004-01-08
December, 2000 FDA 483 Response Patheon Manufacturing Services LLC - Form 483R, 2001-01-03
October, 2005 EIR Patheon Softgels Inc. - EIR, 2005-10-28
March, 2007 FDA 483 Response Leiner Health Product, Llc - Form 483R, 2007-04-09
January, 2000 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-01-14
July, 2000 FDA 483 Societal CDMO Gainesville, LLC - Form 483, 2000-07-26
March, 2002 EIR Societal CDMO Gainesville, LLC - EIR, 2002-03-07
June, 2004 FDA 483 Merck And Company Inc - Form 483, 2004-06-17
March, 2008 FDA 483 Eon Labs, Inc. - Form 483, 2008-03-31
February, 2005 FDA 483 The Ritedose Corporation - Form 483, 2005-02-09
April, 2000 FDA 483 Response NEXAIR, LLC - Form 483R, 2000-05-01
July, 2001 FDA 483 Kiel Laboratories - Form 483, 2001-07-26
April, 2009 EIR Hospira, Inc. - EIR, 2009-04-29
March, 2002 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2002-03-22
November, 2000 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-11-21
March, 2007 FDA 483 Leiner Health Product, Llc - Form 483, 2007-03-16
May, 2001 FDA 483 Boc Group Inc - Form 483, 2001-05-04
September, 2001 FDA 483 Piedmont LLC dba Voyant Beauty - Form 483, 2001-09-11
November, 2000 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2000-11-28
January, 2007 FDA 483 Encompass Pharmaceutical Services Inc. - Form 483, 2007-01-17
February, 2014 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2014-05-15
February, 2010 FDA 483 Hospira, Inc. - Form 483, 2010-02-23
May, 2004 EIR CATALENT GREENVILLE, INC. - EIR, 2004-05-19
May, 2002 EIR Patheon API Manufacturing, Inc. - EIR, 2002-05-23
May, 2001 EIR Boc Group Inc - EIR, 2001-05-04
September, 2003 FDA 483 Cytosol Opthalmics -lenoir, Inc. - Form 483, 2003-09-19
August, 2008 FDA 483 CSL Plasma, Inc - Form 483, 2008-08-29
February, 2010 EIR Hospira, Inc. - EIR, 2010-02-23
February, 2005 EIR The Ritedose Corporation - EIR, 2005-02-09
March, 2013 EIR Hospira, Inc. - EIR, 2013-03-01
November, 2001 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2001-11-09
August, 2011 FDA 483 Hospira, Inc. - Form 483, 2011-08-04
March, 2013 FDA 483 Stewart Compounding Pharmacy - Form 483, 2013-03-25
July, 2004 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2004-07-15
June, 2002 EIR Mikart, LLC - EIR, 2002-06-21
September, 2002 FDA 483 Kiel Laboratories, Inc. - Form 483, 2002-09-17
August, 2001 EIR Mikart, LLC - EIR, 2001-08-23
June, 2002 FDA 483 Mikart, LLC - Form 483, 2002-06-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more